Cargando…
Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma
Genes with altered DNA methylation can be used as biomarkers for cancer detection and assessment of prognosis. Here we analyzed the methylation status of a colorectal cancer biomarker panel (CNRIP1, FBN1, INA, MAL, SNCA, and SPG20) in 97 cancer cell lines, derived from 17 different cancer types. Int...
Autores principales: | Bethge, Nicole, Lothe, Ragnhild A, Honne, Hilde, Andresen, Kim, Trøen, Gunhild, Eknæs, Mette, Liestøl, Knut, Holte, Harald, Delabie, Jan, Smeland, Erlend B, Lind, Guro E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053461/ https://www.ncbi.nlm.nih.gov/pubmed/24362313 http://dx.doi.org/10.4161/epi.27554 |
Ejemplares similares
-
Identification of Highly Methylated Genes across Various Types of B-Cell Non-Hodgkin Lymphoma
por: Bethge, Nicole, et al.
Publicado: (2013) -
A Gene Panel, Including LRP12, Is Frequently Hypermethylated in Major Types of B-Cell Lymphoma
por: Bethge, Nicole, et al.
Publicado: (2014) -
Experimental factors affecting the robustness of DNA methylation analysis
por: Pharo, Heidi D., et al.
Publicado: (2016) -
Novel target genes and a valid biomarker panel identified for cholangiocarcinoma
por: Andresen, Kim, et al.
Publicado: (2012) -
CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers
por: Vedeld, Hege Marie, et al.
Publicado: (2017)